Intuitive Surgical Inc. Takes a Dive: Key Insights and Analyst Expectations

Intuitive Surgical, Inc. (ISRG) closed at $534.65, down 1.8% from the previous day. The company's quarterly earnings are expected to be $1.92, a 7.87% increase from the same quarter last year. Annual earnings are forecasted at $7.84 per share, a 6.81% increase from the previous year. The Zacks Rank is #2 (Buy), and the Forward P/E ratio is 69.44, which is higher than the industry's Forward P/E of 25.22.

Intuitive Surgical, Inc. (ISRG), a leading provider of robotic surgical systems, closed at $534.65 on July 2, 2025, marking a 1.8% decline from the previous day's close. This drop was slightly more pronounced than the broader market, where the S&P 500 lost 0.79%, the Dow dropped 0.94%, and the Nasdaq fell 0.92%. Over the past month, ISRG's stock has underperformed the Medical sector, with a 2.26% loss compared to the sector's 1.49% gain and the S&P 500's 5.22% increase.

Looking ahead, investors are anticipating ISRG's upcoming earnings disclosure. Analysts predict the company will report earnings per share (EPS) of $1.92, representing a 7.87% increase from the same quarter last year. For the full year, the Zacks Consensus Estimates forecast EPS of $7.84 per share, a 6.81% increase from the previous year. Revenue is expected to reach $2.35 billion in the quarter, up 16.81% year-over-year, and $9.65 billion for the year, a 15.56% increase [1].

ISRG's valuation metrics indicate a premium over the industry average. The company is trading at a Forward P/E ratio of 69.44, significantly higher than the Medical - Instruments industry's Forward P/E of 25.22. The PEG ratio, which accounts for expected earnings growth, stands at 4.59, compared to the industry average of 2.26 [1].

The Zacks Rank, an exclusive model that considers changes in analyst estimates, currently rates ISRG as a #2 (Buy) [1]. This ranking reflects a positive outlook on the company's business operations and ability to generate profits.

In summary, while ISRG's recent stock performance has lagged the broader market, the company's strong earnings forecasts and premium valuation metrics suggest a potential for recovery and growth in the coming quarters.

References:
[1] https://www.nasdaq.com/articles/intuitive-surgical-inc-isrg-suffers-larger-drop-general-market-key-insights-1
[2] https://stockanalysis.com/stocks/isrg/